Advertisement Cancer Therapeutics deploys Dotmatics enterprise platform - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cancer Therapeutics deploys Dotmatics enterprise platform

Cancer Therapeutics CRC has selected Dotmatics' enterprise platform for data querying and analysis across its multiple research sites in Australia.

CRC implemented Browser, Dotmatics’ enterprise query platform, and Vortex, a premium data visualization and analysis tool, to enhance data sharing, communication and increase research output.

Cancer Therapeutics CRC medicinal chemistry director Ian Holmes said despite working on opposite sides of the world the entire setup process was efficient and painless.

Vortex will allow scientists to evaluate large datasets in a flexible user interface by providing users with an out-of the-box filtering, charting, plotting and chemically aware calculations engine.

The users can query and report data from a variety of third party and disparate data sources using Browser, which even gives the power back to the user to create complex reports in a fast and simple way, using a web-page interface.